YUMANITY THERAPEUTICS
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Founded in December 2014 by award-winning protein folding expert, Susan Lindquist, and renowned biotech industry leader, Tony Coles, Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimerโs disease, Parkinsonโs... disease, and amyotrophic lateral sclerosis (ALS). The companyโs proprietary platforms have already identified one potential new target for treating Parkinsonโs disease, and Yumanity is actively advancing its new chemical lead series for this condition, as well as identifying additional compounds for Alzheimerโs disease and ALS.
YUMANITY THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.yumanity.com
Total Employee:
11+
Status:
Active
Contact:
(973) 271-6085
Email Addresses:
[email protected]
Total Funding:
137.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Mobile Non Scaleable Content Nginx Sitelinks Search Box
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Venture Round - Yumanity Therapeutics
Ikarian Capital
Ikarian Capital investment in Venture Round - Yumanity Therapeutics
Altium Capital
Altium Capital investment in Venture Round - Yumanity Therapeutics
Stonepine Capital
Stonepine Capital investment in Venture Round - Yumanity Therapeutics
Maven Investment Partners US
Maven Investment Partners US investment in Venture Round - Yumanity Therapeutics
Invus
Invus investment in Venture Round - Yumanity Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Venture Round - Yumanity Therapeutics
Redmile Group
Redmile Group investment in Series A - Yumanity Therapeutics
Alexandria Venture
Alexandria Venture investment in Series A - Yumanity Therapeutics
Dolby Family Ventures
Dolby Family Ventures investment in Series A - Yumanity Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-08-16 | Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants |
Official Site Inspections
http://www.yumanity.com Semrush global rank: 5.64 M Semrush visits lastest month: 1.49 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago